Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials
© 2023. The Author(s)..
We recently reported that according to patients and healthcare professionals in breast cancer and nephrology trials, teams conducting the trials got their choice of primary outcome wrong (72% of the time) more often than they got it right (28% of the time). A Patient and Public Involvement (PPI) representative, co-author of this letter, asked (on Twitter) whether PPI contributors had been involved in the design of the original trials and by extension the outcome selection. The purpose of this study was to answer this question.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Trials - 24(2023), 1 vom: 07. Feb., Seite 93 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Buckley, Ciara [VerfasserIn] |
---|
Links: |
---|
Themen: |
Clinical trials |
---|
Anmerkungen: |
Date Completed 08.02.2023 Date Revised 27.12.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s13063-022-06980-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352571969 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM352571969 | ||
003 | DE-627 | ||
005 | 20231229123830.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13063-022-06980-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1240.xml |
035 | |a (DE-627)NLM352571969 | ||
035 | |a (NLM)36747232 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Buckley, Ciara |e verfasserin |4 aut | |
245 | 1 | 0 | |a Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.02.2023 | ||
500 | |a Date Revised 27.12.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s). | ||
520 | |a We recently reported that according to patients and healthcare professionals in breast cancer and nephrology trials, teams conducting the trials got their choice of primary outcome wrong (72% of the time) more often than they got it right (28% of the time). A Patient and Public Involvement (PPI) representative, co-author of this letter, asked (on Twitter) whether PPI contributors had been involved in the design of the original trials and by extension the outcome selection. The purpose of this study was to answer this question | ||
650 | 4 | |a Letter | |
650 | 4 | |a Clinical trials | |
650 | 4 | |a Outcomes | |
650 | 4 | |a Patient and public involvement/PPI | |
650 | 4 | |a Trial methodology | |
700 | 1 | |a Treweek, Shaun |e verfasserin |4 aut | |
700 | 1 | |a Laidlaw, Lynn |e verfasserin |4 aut | |
700 | 1 | |a Shiely, Frances |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Trials |d 2006 |g 24(2023), 1 vom: 07. Feb., Seite 93 |w (DE-627)NLM161320430 |x 1745-6215 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2023 |g number:1 |g day:07 |g month:02 |g pages:93 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13063-022-06980-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2023 |e 1 |b 07 |c 02 |h 93 |